## Abstract Increased expression of interleukin‐1 (IL‐1) in skin elicits a variety of responses, including inflammation and epidermal hyperplasia, which are also characteristic events elicited by tumor promoters. The goal of this study was to investigate whether various classes of tumor promoters i
Elevation of transforming growth factor-α mRNA and protein expression by diverse tumor promoters in sencar mouse epidermis
✍ Scribed by Kaoru Kiguchi; Linda M. Beltrán; Jinsong You; Okkyung Rho; John Digiovanni
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 908 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0899-1987
No coin nor oath required. For personal study only.
✦ Synopsis
The study presented here was designed t o further investigate the role o f transforming growth factor-a (TGFa) in skin tumor promotion by examining the ability of 12-O-tetradecanoylphorbol-l3-acetate (TPA) and several non-phorbol ester promoters t o alter TGFa mRNA and protein levels in mouse epidermis. Total RNA was isolated from SENCAR mouse epidermis at various times after single topical treatments with TPA (3.4 nmol), chrysarobin (220 nmol), okadaic acid (2.5 nmol), and thapsigargin (8.5 nmol). Northern analyses of these isolated RNA samples revealed that all four tumor promoters transiently elevated TGFa mRNA levels. Whereas TPA, okadaic acid, and thapsigarin elevated TGFamRNA levels over similar time courses (peak at 4-8 h), chrysarobin elevated TGFa mRNA levels with a markedly delayed time course (peak at 24-48 h). More detailed studies with TPA also revealed that multiple treatments (four over a 2-wk period) transiently elevated TGFa mRNA in both the epidermis and the dermis. The time courses for changes in TGFa mRNA after multiple TPA treatments were similar for both tissues. To facilitate studies of altered TGFa mRNA expression in mouse epidermis and possibly other mouse tissues, a semiquantitative reverse transcriptase-polymerase chain reaction method was developed. This method faithfully revealed changes in TGFa mRNA levels with all four tumorpromoting agents similar t o those determined by northern blot analyses. lmmunofluorescence analysis of frozen sections from promoter-treated skin revealed elevated TGFa protein levels in both epidermis and dermis, although staining was most intense in the epidermal layer. lmmunofluorescence analysis o f epidermal hyperplasia adjacent t o a full-thickness wound also demonstrated significant epidermal TGFa staining. Collectively, these results indicate that mechanistically diverse tumor promoter stimuli elevate TGFa mRNA and protein in SENCAR mouse epidermis. Elevated levels of TGFa may play an essential role in mitogenic stimulation during tumor promotion by diverse promoting stimuli.
📜 SIMILAR VOLUMES
## Abstract Transforming growth factor (TGF)‐β1, whose gene is located on mouse chromosome 7, has been proposed to be involved in skin carcinogenesis. In the study presented here, we demonstrated that single topical treatments with different types of tumor promoters, i.e., the protein kinase C acti
Multiple epidermal growth factor receptor (EGFr) ligands have been identified, including transforming growth factor α (TGFα), heparin-binding epidermal growth factor (HB-EGF), amphiregulin (AR), and betacellulin (BTC). Previous work from our laboratory demonstrated that TGFα mRNA and protein are upr
Insulin-like growth factor-1 (IGF-1) and its receptor are believed to play an important role in mitogenesis and neoplastic transformation. The purpose of this study was to further examine the role of IGF-1 during tumor promotion in mouse skin. HK1.IGF1 transgenic mice, which overexpress IGF-1 in epi
The flavonoid antioxidant silymarin is used clinically in Europe and Asia for the treatment of liver diseases and is sold in the United States and Europe as a dietary supplement. Recently we showed that silymarin possesses exceptionally high cancer-preventive effects in different mouse skin carcinog